...
首页> 外文期刊>Geriatrics & gerontology international. >Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)
【24h】

Effects on agitation with rivastigmine patch monotherapy and combination therapy with memantine in mild to moderate Alzheimer's disease: a multicenter 24-week prospective randomized open-label study (the Korean EXelon Patch and combination with mEmantine Comparative Trial study)

机译:用牛肝菌蛋白疗法搅动的影响和致癌物质与温和至中等阿尔茨海默病的组合治疗:多中心24周前瞻性随机开放标签研究(韩国优先蛋白贴片和与Memantine比较试验研究的组合)

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: Memantine is known to be effective in the treatment of the behavioral symptoms of dementia, especially agitation in moderate to severe Alzheimer's disease (AD). However, memantine and rivastigmine patch combination therapy has not been well studied in determining treatment effectiveness with mild to moderate AD patients.
机译:目的:众所周知,致念珠菌治疗痴呆的行为症状,尤其是中度至严重的阿尔茨海默病(AD)的搅拌。 然而,在测定与轻度至中度AD患者的治疗效果中没有很好地研究了Memantine和Rivastigmine蛋白联合治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号